Anti-herpes Virus Activity of the Carnivorous Botanical, Sarracenia Purpurea

Overview

Journal Sci Rep

Specialty Science

Date 2020 Nov 4

PMID 33144625

Citations 5

Authors

Latha Kannan

Ashok Kumar

Aradhana Kumar

Bertram Jacobs

Jeffrey Langland

Affiliations

Soon will be listed here.

Abstract

Herpes simplex virus type-1 (HSV-1), one of the most widely spread human viruses in the Herpesviridae family, causes herpes labialis (cold sores) and keratitis (inflammation of the cornea). Conventional treatment for HSV-1 infection includes pharmaceutical drugs, such as acyclovir and docosonal, which are efficacious but maintain the potential for the development of viral drug resistance. Extracts from the carnivorous pitcher plant, Sarracenia purpurea, have previously been shown to inhibit the replication of HSV-1. In this study, we demonstrate that S. purpurea extracts can inhibit the replication of HSV-1 by two distinct mechanisms of action. These extracts directly inhibit extracellular virions or viral attachment to the human host cell as well as inhibiting the expression of viral immediate-early, early and late genes when added at various times post-infection. This botanical has previously been shown to inhibit the replication of poxviruses through the inhibition of early viral gene transcription. These results support a broader anti-viral activity of S. purpurea extracts against both pox and herpes viruses.

Citing Articles

Therapeutic effects of acyclovir and acyclovir-clobetasol nanofibers vs. cream formulation for recurrent herpes labialis.

Mirzaei S, Nejad Z, Khozaimeh F, Mohammadi S, Loqmani A BMC Oral Health. 2024; 24(1):1348.

PMID: 39506756 PMC: 11539845. DOI: 10.1186/s12903-024-04948-6.

Herpes simplex keratitis: A brief clinical overview.

Musa M, Enaholo E, Aluyi-Osa G, Atuanya G, Spadea L, Salati C World J Virol. 2024; 13(1):89934.

PMID: 38616855 PMC: 11008405. DOI: 10.5501/wjv.v13.i1.89934.

A Systematic Review of Second-Line Treatments in Antiviral Resistant Strains of HSV-1, HSV-2, and VZV.

Lince K, DeMario V, Yang G, Tran R, Nguyen D, Sanderson J Cureus. 2023; 15(3):e35958.

PMID: 37041924 PMC: 10082683. DOI: 10.7759/cureus.35958.

Secondary Metabolites with Biomedical Applications from Plants of the Sarraceniaceae Family.

Miclea I Int J Mol Sci. 2022; 23(17).

PMID: 36077275 PMC: 9456395. DOI: 10.3390/ijms23179877.

A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy.

Saifulazmi N, Rohani E, Harun S, Bunawan H, Hamezah H, Nor Muhammad N Life (Basel). 2022; 12(8).

PMID: 36013466 PMC: 9410304. DOI: 10.3390/life12081287.

References

Ito M, Sato A, Hirabayashi K, Tanabe F, Shigeta S, Baba M . Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res. 1988; 10(6):289-98. DOI: 10.1016/0166-3542(88)90047-2. View

Kost R, Hill E, Tigges M, Straus S . Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med. 1993; 329(24):1777-82. DOI: 10.1056/NEJM199312093292405. View

Cocchi F, Fusco D, Menotti L, Gianni T, Eisenberg R, Cohen G . The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry. Proc Natl Acad Sci U S A. 2004; 101(19):7445-50. PMC: 409938. DOI: 10.1073/pnas.0401883101. View

Nicola A, McEvoy A, Straus S . Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol. 2003; 77(9):5324-32. PMC: 153978. DOI: 10.1128/jvi.77.9.5324-5332.2003. View

Langland J, Jacobs B, Wagner C, Ruiz G, Cahill T . Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses. Antiviral Res. 2018; 160:143-150. DOI: 10.1016/j.antiviral.2018.10.021. View

Partridge M, POSWILLO D . Topical carbenoxolone sodium in the management of herpes simplex infection. Br J Oral Maxillofac Surg. 1984; 22(2):138-45. DOI: 10.1016/0266-4356(84)90026-3. View

Nugier F, Colin J, Aymard M, Langlois M . Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J Med Virol. 1992; 36(1):1-12. DOI: 10.1002/jmv.1890360102. View

MacLeod D, Nakatsuji T, Yamasaki K, Kobzik L, Gallo R . HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection. Nat Commun. 2013; 4:1963. PMC: 3681428. DOI: 10.1038/ncomms2963. View

Kimberlin D, Crumpacker C, Straus S, Biron K, Drew W, Hayden F . Antiviral resistance in clinical practice. Antiviral Res. 1995; 26(4):423-38. DOI: 10.1016/0166-3542(95)00031-g. View

10.

Andrei G, Georgala A, Topalis D, Fiten P, Aoun M, Opdenakker G . Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy. J Infect Dis. 2013; 207(8):1295-305. DOI: 10.1093/infdis/jit019. View

11.

Baba M, Shigeta S . Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res. 1987; 7(2):99-107. DOI: 10.1016/0166-3542(87)90025-8. View

12.

Perng G, Jones C . Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis. 2010; 2010:262415. PMC: 2822239. DOI: 10.1155/2010/262415. View

13.

Looker K, Garnett G . A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect. 2005; 81(2):103-7. PMC: 1764655. DOI: 10.1136/sti.2004.012039. View

14.

Gupta R, Warren T, Wald A . Genital herpes. Lancet. 2007; 370(9605):2127-37. DOI: 10.1016/S0140-6736(07)61908-4. View

15.

Shim Y, Doo H, Ahn S, Kim Y, Seong J, Park I . Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. J Ethnopharmacol. 2003; 85(2-3):283-7. DOI: 10.1016/s0378-8741(02)00370-7. View

16.

Ho D . Herpes simplex virus latency: molecular aspects. Prog Med Virol. 1992; 39:76-115. View

17.

Chen T, Chen D, Wen H, Ou J, Chiou S, Chen J . Inhibition of enveloped viruses infectivity by curcumin. PLoS One. 2013; 8(5):e62482. PMC: 3641039. DOI: 10.1371/journal.pone.0062482. View

18.

Zhou C, Knipe D . Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme. J Virol. 2002; 76(12):5893-904. PMC: 136207. DOI: 10.1128/jvi.76.12.5893-5904.2002. View

19.

Jassim S, Naji M . Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol. 2003; 95(3):412-27. DOI: 10.1046/j.1365-2672.2003.02026.x. View

20.

Dauber B, Saffran H, Smiley J . The herpes simplex virus 1 virion host shutoff protein enhances translation of viral late mRNAs by preventing mRNA overload. J Virol. 2014; 88(17):9624-32. PMC: 4136367. DOI: 10.1128/JVI.01350-14. View